Effectiveness of Nurse led palliative care on symptom burden and quality of life among cancer patients: A randomized controlled trial.
Not Applicable
Not yet recruiting
- Conditions
- Health Condition 1: C50-C50- Malignant neoplasms of breast
- Registration Number
- CTRI/2022/04/042329
- Lead Sponsor
- Government Rajindra hospital Patiala
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Not Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
1. Able to follow instructions.
2. Willing to participate in the study.
3. Able to communicate in Hindi or Punjabi or English.
4. Performance status between 30 to 70.
Exclusion Criteria
1. In remission stage.
2. Unconscious.
3. With mental retardation, epilepsy, personality disorders, cognitive dysfunction, active substance use.
4. With primary lymphedema.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
What molecular mechanisms underlie symptom burden reduction in nurse-led palliative care for breast cancer patients?
How does nurse-led palliative care compare to standard-of-care in managing ERBB2-positive breast cancer symptoms?
Are there specific biomarkers that predict quality of life improvements from nurse-led palliative interventions in C50-C50 malignancies?
What adverse events are associated with nurse-led palliative care models versus physician-led approaches in oncology?
What combination therapies show enhanced effectiveness when paired with nurse-led palliative care for metastatic breast cancer patients?